Antikörper gegen Mikropartikel
G. Hron et al.: Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer, Thromb Haemost 2007
B. Steppich et al.: Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction, Thromb Haemost 2005
J.F. Keuren et al.: Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation., Br J Haematol. 2006
J.M. Wang et al.: Increased Circulating CD31+/CD42- Microparticles Are Associated With Impaired Systemic Artery Elasticity in Healthy Subjects., Am J Hypertens. 2007
G. Chironi et al.: Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects., Arterioscler Thromb Vasc Biol. 2006
W.A. Sheremata et al.: Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis., J Neuroinflammation 2006